After the data collection and processing you can finally start analysing your data. These guidelines provide guidance in that process:
- Analysis plan
- Initial data analysis
- Post-hoc and sensitivity analyses
- Data analysis documentation
- Prognostic models
- Handling missing data
- Please note, that there are stricter requirements (trial master file and eCRF e.g.) for Clinical Trials with pharmaceuticals and Medical devices that fall under GCP regulation/ WMO-high/medium risk.